搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
3 小时
ADHD symptoms, myths, treatment strategies of this neurodevelopmental disorder
Difficulty focusing, hyperactivity, and impulsive behaviour are key signs of ADHD. If your child has this neurodevelopmental ...
News Medical
7 小时
Researchers uncover brain mechanisms that help overcome instinctive fears
Researchers at the (SWC) at UCL have unveiled the precise brain mechanisms that enable animals to overcome instinctive fears.
12 小时
A step towards personalized immunotherapy: MIRO device replicates tumors, environments and ...
A team led by the Institute for Bioengineering of Catalonia (IBEC) and the Hospital del Mar Research Institute has developed ...
16 小时
Psychotherapy may change memories of childhood—here's why practitioners should warn clients
One of the unfortunate legacies that my generation, gen X, has passed on to the millennials and gen Z, is the idea that ...
16 小时
Denali Therapeutics Announces Primary Analysis and Long-Term Follow-Up of Phase 1/2 Study ...
Long-term data demonstrate that robust reductions and normalization in key biomarkers from baseline were maintained over time with continued ...
17 小时
Denali Therapeutics announces primary analysis of Phase 1/2 study in MPS II
Denali Therapeutics (DNLI) announced the primary analysis of the Phase 1/2 study in 47 participants with Hunter syndrome in the 24-week ...
FierceBiotech
17 小时
Denali eyes approval after Hunter syndrome drug clears safety measures, reduces biomarkers ...
After winning a breakthrough therapy designation for its Hunter syndrome enzyme replacement therapy, Denali Therapeutics is ...
Le Lézard
20 小时
Spring Health Study Published in JAMA Network Open Demonstrates 1.9x ROI of Employer ...
Health, the leading global mental health solution for employers and health plans, today unveiled data from a peer-reviewed study that validates the return on investment (ROI) of employer-sponsored ...
21 小时
Palatin Completes Phase 2 Obesity Study With MC4R Bremelanotide Plus GLP-1/GIP Tirzepatide
Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on ...
News Medical
22 小时
Advancing living materials with precise control over mechanical properties
Rice University researchers have revealed novel sequence-structure-property relationships for customizing engineered living ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈